Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan-Dec:27:10760296211010241.
doi: 10.1177/10760296211010241.

Blood Urea Nitrogen to Serum Albumin Ratio Independently Predicts Mortality in Critically Ill Patients With Acute Pulmonary Embolism

Affiliations

Blood Urea Nitrogen to Serum Albumin Ratio Independently Predicts Mortality in Critically Ill Patients With Acute Pulmonary Embolism

Jihong Fang et al. Clin Appl Thromb Hemost. 2021 Jan-Dec.

Abstract

Acute pulmonary embolism (APE) is one of the prominent causes of death in patients with cardiovascular disease. Currently, reliable biomarkers to predict the prognosis of patients with APE are limited. The present study aimed to investigate the association of blood urea nitrogen to serum albumin (B/A) ratio and intensive care unit (ICU) mortality in critically ill patients with APE. A retrospective cohort study was performed using data extracted from a freely accessible critical care database (MIMIC-III). Adult (≥18 years) patients of first ICU admission with a primary diagnosis of APE in the database were enrolled in the study. The primary endpoint was the ICU mortality rate while the 28-day mortality after ICU admission was the secondary endpoint. The data of survivors and non-survivors were compared. A total of 1048 patients with APE were enrolled in this study, of which 131 patients died in ICU and 169 patients died within 28 days after ICU admission. The B/A ratio in the non-survivors group was significantly higher compared to the survivors group (P < 0.001). The multivariate analysis revealed that the B/A ratio was an independent predictor of ICU mortality (odds ratio [OR] 1.10, 95% CI 1.07-1.14, P < 0.001) and all-cause mortality within 28 days after ICU admission (hazard ratio [HR] 1.07, 95% CI 1.05-1.09, P < 0.001) in APE patients. The B/A ratio showed a greater area under the curve (AUC) of ICU mortality prediction (0.80; P < 0.001) than simplified acute physiology score II (SAPSII) (0.79), systemic inflammatory response syndrome score (SIRS) (0.62), acute physiology score III (APSIII) (0.76) and sequential organ failure assessment (SOFA) score (0.71). The B/A ratio could be a simple and useful prognostic tool to predict mortality in critically ill patients with APE.

Keywords: acute pulmonary embolism; blood urea nitrogen to serum albumin ratio; critical care; hospital mortality.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flow chart of the study participants.
Figure 2.
Figure 2.
Receiver-operating characteristic curve of the B/A ratio, BUN, SAPSII, SIRS, SOFA and APSIII to predict ICU mortality of APE. Abbreviations: B/A ratio, blood urea nitrogen to serum albumin ratio; BUN, blood urea nitrogen; SAPSII, simplified acute physiology score II; SIRS, systemic inflammatory response syndrome score; SOFA, sequential organ failure assessment; APSIII, acute physiology score III; ICU, intensive care unit; APE, acute pulmonary embolism.
Figure 3.
Figure 3.
Kaplan-Meier curves of the B/A ratio for predicting 28-day mortality with APE. A high B/A ratio was significantly associated with higher mortality than a low B/A ratio (P < 0.001). Abbreviation: B/A ratio: blood urea nitrogen to serum albumin ratio.

Similar articles

Cited by

References

    1. Konstantinides SV, Torbicki A, Agnelli G, et al. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–3080. doi:10.1093/eurheartj/ehu283 - PubMed
    1. Bach AG, Taute BM, Baasai N, et al. 30-day mortality in acute pulmonary embolism: prognostic value of clinical scores and anamnestic features. PLoS One. 2016;11(2):e0148728. doi:10.1371/journal.pone.0148728 - PMC - PubMed
    1. Kucher N, Rossi E, De Rosa M, et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med. 2005;165(15):1777–1781. doi:10.1001/archinte.165.15.1777 - PubMed
    1. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronicthromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–1830. doi:10.1161/CIR.0b013e318214914 f. - PubMed
    1. El-Menyar A, Sathian B, Al-Thani H. Elevated serum cardiac troponin and mortality in acute pulmonary embolism: Systematic review and meta-analysis. Respir Med. 2019;157: 26–35. doi:10.1016/j.rmed.2019.08.011 - PubMed